Cyclic Nucleotide Systems in the Microcirculation of Mammalian Brain

  • G. C. Palmer
  • S. J. Palmer
  • R. B. Chronister
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 131)


The cellular elements of the central microcirculation, namely the capillaries, choroid plexus and pia, contain adrenergic nerve endings whose functions may be involved in the regulation of permeability (1–6). An important aspect of noradrenergic action is stimulation of the receptor enzyme, adenylate cyclase with concomitant formation of adenosine cyclic 3′,5′-monophosphate (cyclic AMP). Recent work that I did with co-investigators (7–10) and the works of others (11–15) showed that the cellular components of the microcirculation contain active adenylate cyclase systems capable of responding to a variety of neurohumoral agonists, including norepinephrine. Joō (16) found that an infusion of dibutyryl cyclic AMP yielded an enhanced number of pinocytotic vesicles in mouse cerebral capillaries, and suggested that the cyclic nucleotide has a role in central nervous system transport mechanisms. In this chapter I will discuss our previous work and present new data characterizing the specific nature of the receptor enzymes in rat and rabbit cerebral microvessels. In addition, since the cerebral capillaries develop altered permeability in certain pathologic conditions such as hypertension (6,17–19), we will report changes seen in the cyclase system of cerebral capillaries from the spontaneously hypertensive rats (SHR).


Adenylate Cyclase Choroid Plexus Cyclic Nucleotide Brain Capillary Pinocytotic Vesicle 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hartman BK, Zide D, Udenfriend S: The use of dopamine β-hydroxylase as a marker for the central noradrenergic nervous system in rat brain. Proc Natl Acad Sci (USA) 69: 2722–2726, 1972.CrossRefGoogle Scholar
  2. 2.
    Hartman BK, Swanson LW, Raichle ME, et al: Evidence for central adrenergic regulation of cerebral vascular permeability and blood flow. In, Usdin E, Kopin IJ and Barchas J (eds): Catecholamines: Basic and Clinical Frontiers, New York, Pergamon Press, 1979, pp 450–452.Google Scholar
  3. 3.
    Raichle ME, Hartman BK, Eichling JO, et al: Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci (USA) 72: 3726–3730, 1975.CrossRefGoogle Scholar
  4. 4.
    Grubb RL Jr, Raichle ME, Eichling JO: Peripheral sympathetic regulation of brain water permeability. Brain Res 144: 204–207, 1978.CrossRefPubMedGoogle Scholar
  5. 5.
    Goldberg LI: The dopamine vascular receptor. Biochem Pharmacol 25: 651–653, 1975.CrossRefGoogle Scholar
  6. 6.
    Edvinsson L, MacKenzie ET: Amine mechanisms in the cerebral circulation. Pharmacol Rev 28: 276–348, 1977.Google Scholar
  7. 7.
    Palmer GC, Palmer SJ: 5′-guanylyl-imidodiphosphate actions on adenylate cyclase in homogenates of rat cerebral cortex plus neuronal and capillary fractions. Life Sci 23: 207–216, 1978.CrossRefPubMedGoogle Scholar
  8. 8.
    Baca GM, Palmer GC: Presence of hormonally-sensitive adenylate cyclase receptors in capillary-enriched fractions from rat cerebral cortex. Blood Vessels 15: 286–298, 1978.PubMedGoogle Scholar
  9. 9.
    Palmer GC: Beta adrenergic receptors mediate adenylate cyclase responses in rat cerebral capillaries. Neuropharmacology 28: 2847–2849, 1979.Google Scholar
  10. 10.
    Palmer GC: Diminished adenylate cyclase responses in frontal cortex and cerebral capillaries of spontaneously hypertensive rats. Biochem Pharmacol, in press.Google Scholar
  11. 11.
    Joō F, Rakonczay Z, Wollemann M: cAMP-mediated regulation of the permeability in the brain capillaries. Experientia 31: 582–584, 1975.CrossRefPubMedGoogle Scholar
  12. 12.
    Joō F, Toth I: Brain adenylate cyclase: Its common occurrence in the capillaries and astrocytes. Die Naturwissenschaften 62: 397, 1975.PubMedGoogle Scholar
  13. 13.
    Hammers R, Clarenbach P, Lindl T, et al: Uptake and metabolism of cyclic AMP in rabbit choroid plexus in vitro. Neuropharmacology 16: 135–141, 1977.CrossRefPubMedGoogle Scholar
  14. 14.
    Herbst TJ, Raichle ME, Ferrendelli JA: β-adrenergic regulation of adenosine 3′,5′-monophosphate concentration in brain microvessels. Science 204: 330–332, 1979.CrossRefPubMedGoogle Scholar
  15. 15.
    Nathanson JA, Glaser GH: Identification of β-adrenergic-sensitive adenylate cyclase in intracranial blood vessels. Nature (Lond) 278: 567–569, 1979.CrossRefGoogle Scholar
  16. 16.
    Joō F: Effect of N6O2-dibutyryl cyclic 3′,5′-adenosine monophosphate on the pinocytosis of brain capillaries of mice. Experientia 28: 1470–1471, 1972.CrossRefPubMedGoogle Scholar
  17. 17.
    Hazama F, Amano S, Ozaki T: Pathological changes of cerebral vessel endothelial cells in spontaneously hypertensive rats, with special reference to the role of these cells in the development of hypertensive cerebrovascular lesions. Advan Neurol 20: 359–369, 1978.PubMedGoogle Scholar
  18. 18.
    Dinsdale HB: Hypertension and the blood-brain barrier. Advan Neurol 20: 341–346, 1978.PubMedGoogle Scholar
  19. 19.
    Brondsted HE, Westergaard E: Increased vesicular transport of horseradish peroxidase across the blood-brain barrier after chemical induction of hypertension. Advan Neurol 20: 347–348, 1978.PubMedGoogle Scholar
  20. 20.
    Joō F, Karnushina I: A procedure for the isolation of capillaries from rat brain. Cytobios 8: 41–48, 1973.PubMedGoogle Scholar
  21. 21.
    Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin reagent. J Biol Chem 193: 265–275, 1951.PubMedGoogle Scholar
  22. 22.
    Palmer GC: Interactions of antiepileptic drugs on adenylate cyclase and phosphodiesterases in rat and mouse cerebrum. Exp Neurol 63: 322–335, 1979.CrossRefPubMedGoogle Scholar
  23. 23.
    Henry PD, Dobson JG Jr, Sobel BE: Dissociations between changes in myocardial cyclic adenosine monophosphate and contractility. Circ Res 36: 392–400, 1975.CrossRefPubMedGoogle Scholar
  24. 24.
    Uzunov P, Weiss B: Separation of multiple molecular forms of cyclic adenosine 3′,5′-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis. Biochim Biophys Acta 284: 220–226, 1972.CrossRefPubMedGoogle Scholar
  25. 25.
    Segel IH: Enzyme Kinetics, New York, John Wiley and Sons, 1975, pp 53–54.Google Scholar
  26. 26.
    Palmer GC: Beta adrenergic and dopamine (DA) receptors in brain capillaries. In, Usdin E, Kopin IJ, and Barchas J (eds): Catecholamines: Basic and Clinical Frontiers, New York, Pergamon Press, 1979, pp 498–500,Google Scholar
  27. 27.
    Rodbell M, Lin MC, Salomon Y, Londos C, et al: Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: Evidence for multisite transition states. Advan Cyclic Nucleotide Res 5: 3–29, 1975.Google Scholar
  28. 28.
    Schmidt MJ: Perspectives on dopamine-sensitive adenylate cyclase in the brain. In, Palmer GC (ed): Neuro-pharmacology of Cyclic Nucleotides, Baltimore, Urban and Schwarzenberg, 1979, pp 1–52.Google Scholar
  29. 29.
    Nathanson JA: Beta-adrenergic receptor in mammalian choroid plexus. Soc Neurosci 4: 517, 1978.Google Scholar
  30. 30.
    Amer MS: Cyclic adenosine monophosphate and hypertension in rats. Science 179: 807–809, 1973.CrossRefPubMedGoogle Scholar
  31. 31.
    Triner L, Vulliemoz Y, Verosky M, et al: Cyclic adenosine monophosphate and vascular reactivity in spontaneously hypertensive rats. Biochem Pharmacol 24: 743–745, 1975.CrossRefPubMedGoogle Scholar
  32. 32.
    Ramanathan S, Shibata S, Tasaki TK, et al: Cyclic AMP metabolism in the cardiac tissue of the spontaneously hyper-tensive rat. Biochem Pharmacol 25: 223–225, 1976.CrossRefPubMedGoogle Scholar
  33. 33.
    Palmer GC, Greenberg S: Supersensitivity and subsensitivity of cortical adenylate cyclase in spontaneously hypertensive rats following chronic administration of pro-pranolol or clonidine. Prog Neuro-Psychopharmacol 2: 585–587, 1979.CrossRefGoogle Scholar
  34. 34.
    Palmer GC, Greenberg: Alternations in myocardial adenylate cyclase in spontaneously hypertensive rats. Pharmacology 19: 156–162, 1979.CrossRefPubMedGoogle Scholar
  35. 35.
    Versteeg DHG, Palkovitz M, van der Gugten J, et al: Catecholamine content of individual brain regions of spon-taneously hypertensive rats (SH-rats). Brain Res 112: 427–434, 1976.CrossRefGoogle Scholar
  36. 36.
    Dismukes RK, Daly JW: Adaptive responses of brain cyclic AMP-generating systems to alterations in synaptic input. J Cyclic Nucleotide Res 2: 321–336, 1976.PubMedGoogle Scholar
  37. 37.
    Wagner HR, Palmer GC, Davis JN: Sensitivity of noradrenergically mediated cyclic AMP responses in the brain. In, Palmer GC (ed): Neuropharmacology of Cyclic Nucleotides, Baltimore, Urban and Schwarzenberg, 1979, pp 152–172.Google Scholar
  38. 38.
    Joō F, Szucs A, Csanda E: Metiamide-treatment of brain oedema in animals exposed to 90yttrium irradiation. J Pharm Pharmacol 28: 162–163, 1976.CrossRefPubMedGoogle Scholar
  39. 39.
    LeBeux YJ, Willemot J: Actin-like filaments in the endothelial cells of adult rat brain capillaries. Exp Neurol 58: 446–454, 1978.CrossRefGoogle Scholar
  40. 40.
    Larner J: Cyclic nucleotides. In, Current Concepts, Upjohn Company, Kalamazoo, 1977, pp 5–52.Google Scholar
  41. 41.
    Greengard P: Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters. Nature (Lond) 260: 10–108, 1976.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • G. C. Palmer
    • 1
    • 2
  • S. J. Palmer
    • 1
    • 2
  • R. B. Chronister
    • 1
    • 2
  1. 1.Department of PharmacologyUniversity of South Alabama College of MedicineMobileUSA
  2. 2.Department of AnatomyUniversity of South Alabama College of MedicineMobileUSA

Personalised recommendations